[1]
|
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Piñeros, M., et al. (2019) Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer, 144, 1941-1953. https://doi.org/10.1002/ijc.31937
|
[2]
|
Chen, W., Zheng, R., Baade, P., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[3]
|
Song, M., Rabkin, C. and Camargo, M. (2018) Gastric Cancer: An Evolving Disease. Current Treatment Options in Gastroenterology, 16, 561-569. https://doi.org/10.1007/s11938-018-0203-1
|
[4]
|
Ito, N., Tsujimoto, H., Ueno, H., Xie, Q. and Shinomiya, N. (2020) Helicobacter pylori-Mediated Immunity and Signaling Transduction in Gastric Cancer. Journal of Clinical Medicine, 9, Article No. 3699.
https://doi.org/10.3390/jcm9113699
|
[5]
|
Pradere, J., Dapito, D. and Schwabe, R. (2014) The Yin and Yang of Toll-Like Receptors in Cancer. Oncogene, 33, 3485-3495. https://doi.org/10.1038/onc.2013.302
|
[6]
|
Varga, M. and Peek, R. (2017) DNA Transfer and Toll-Like Receptor Modulation by Helicobacter pylori. In: Tegtmeyer N. and Backert, S., Eds., Molecular Pathogenesis and Signal Transduction by Helicobacter pylori, Vol. 400, Springer, Cham, 169-193. https://doi.org/10.1007/978-3-319-50520-6_8
|
[7]
|
Kasurinen, A., Hagström, J., Laitinen, A., Kokkola, A., Böckelman, C. and Haglund, C. (2019) Evaluation of Toll-Like Receptors as Prognostic Biomarkers in Gastric Cancer: High Tissue TLR5 Predicts a Better Outcome. Scientific Reports, 9, Article No. 12553. https://doi.org/10.1038/s41598-019-49111-2
|
[8]
|
Susi, M., Lourenço Caroline, M., Rasmussen, L., Payão, S.L.M., Rossi, A.F.T., Silva, A.E., et al. (2019) Toll-Like Receptor 9 Polymorphisms and Helicobacter pylori Influence Gene Expression and Risk of Gastric Carcinogenesis in the Brazilian Population. World Journal of Gastrointestinal Oncology, 11, 998-1010.
https://doi.org/10.4251/wjgo.v11.i11.0000
|
[9]
|
Nemati, M., Larussa, T., Khorramdelazad, H., Mahmoodi, M. and Jafarzadeh, A. (2017) Toll-Like Receptor 2: An Important Immunomodulatory Molecule during Helicobacter pylori Infection. Life Sciences, 178, 17-29.
https://doi.org/10.1016/j.lfs.2017.04.006
|
[10]
|
Meliț, L., Mărginean, C., Mărginean, C. and Mărginean, M.O. (2019) The Relationship between Toll-Like Receptors and Helicobacter pylori-Related Gastropathies: Still a Controversial Topic. Journal of Immunology Research, 2019, Article ID: 8197048. https://doi.org/10.1155/2019/8197048
|
[11]
|
Neuper, T., Frauenlob, T., Sarajlic, M., Posselt, G., Wessler, S and Horejs-Hoeck, J. (2020) TLR2, TLR4 and TLR10 Shape the Cytokine and Chemokine Release of H. pylori-Infected Human DCs. International Journal of Molecular Sciences, 21, Article No. 3897. https://doi.org/10.3390/ijms21113897
|
[12]
|
Liu, Y., Yu, L., Ying, L., Balic, J., Gao, H., Deng, N.T., et al. (2019) Toll-Like Receptor 2 Regulates Metabolic Reprogramming in Gastric Cancer via Superoxide Dismutase 2. International Journal of Cancer, 144, 3056-3069.
https://doi.org/10.1002/ijc.32060
|
[13]
|
Cao, D., Wu, Y., Jia, Z., Zhao, D., Zhang, Y., Zhou, T., et al. (2019) 18β-Glycyrrhetinic Acid Inhibited Mitochondrial Energy Metabolism and Gastric Carcinogenesis through Methylation-Regulated TLR2 Signaling Pathway. Carcinogenesis, 40, 234-245. https://doi.org/10.1093/carcin/bgy150
|
[14]
|
Kim, Y., Gupta Vallur, P., Phaëton, R., Mythreye, K. and Hempel, N. (2017) Insights into the Dichotomous Regulation of SOD2 in Cancer. Antioxidants, 6, Article No. 86. https://doi.org/10.3390/antiox6040086
|
[15]
|
Kalkanli Tas, S., Kirkik, D., Tanoglu, A., Kahraman, R., Ozturk, K., Esen, M.F., et al. (2020) Polymorphisms in Toll-Like Receptors 1, 2, 5, and 10 Are Associated with Predisposition to Helicobacter pylori Infection. European Journal of Gastroenterology & Hepatology, 32, 1141-1146. https://doi.org/10.1097/MEG.0000000000001797
|
[16]
|
Lourenço, C., Susi, M., Do Nascimento, M., Serafim Junior, V., Vila, A.P.S., Rodrigues-Flemming, G.H., et al. (2020) Characterization and Strong Risk Association of TLR2 del −196 to −174 Polymorphism and Their Influence on mRNA Expression in Gastric Cancer. World Journal of Gastrointestinal Oncology, 12, 535-548.
https://doi.org/10.4251/wjgo.v12.i5.535
|
[17]
|
Zhao, D., Wu, Y., Zhao, T., Jia, Z.F., Cao, D.H., Yang, N., et al. (2019) Single-Nucleotide Polymorphisms in Toll-Like Receptor Genes Are Associated with the Prognosis of Gastric Cancer and Are Not Associated with Helicobacter pylori Infection. Infection, Genetics and Evolution, 73, 384-389. https://doi.org/10.1016/j.meegid.2019.06.005
|
[18]
|
Eed, E., Hawash, Y., Khalifa, A., Alsharif, K.F., Alghamdi, S.A., Almalki, A.A., et al. (2020) Association of Toll-Like Receptors 2, 4, 9 and 10 Genes Polymorphisms and Helicobacter pylori-Related Gastric Diseases in Saudi Patients. Indian Journal of Medical Microbiology, 38, 94-100. https://doi.org/10.4103/ijmm.IJMM_20_164
|
[19]
|
Huang, J., Hang, J., Qin, X., Huang, J. and Wang, X.Y. (2019) Interaction of H. pylori with Toll-Like Receptor 2-196 to -74 Ins/Del Polymorphism Is Associated with Gastric Cancer Susceptibility in Southern China. International Journal of Clinical Oncology, 24, 494-500. https://doi.org/10.1007/s10147-018-1379-z
|
[20]
|
Kim, T., Lee, S., Oh, B., Lee, H., Uhm, T.G., Min, J.K., et al. (2016) Epigenetic Modification of TLR4 Promotes Activation of NF-κB by Regulating Methyl-CpG-Binding Domain Protein 2 and Sp1 in Gastric Cancer. Oncotarget, 7, 4195-4209. https://doi.org/10.18632/oncotarget.6549
|
[21]
|
Krzysiek-Maczka, G., Targosz, A., Szczyrk, U., Strzalka, M., Brzozowski, T. and Ptak-Belowska, A. (2019) Involvement of Epithelial-Mesenchymal Transition-Inducing Transcription Factors in the Mechanism of Helicobacter pylori-Induced Fibroblasts Activation. Journal of Physiology and Pharmacology, 70, 727-736.
|
[22]
|
Hu, L., Zang, M., Wang, H., Li, J.F., Su, L.P., Yan, M., et al. (2016) Biglycan Stimulates VEGF Expression in Endothelial Cells by Activating the TLR Signaling Pathway. Molecular Oncology, 10, 1473-1484.
https://doi.org/10.1016/j.molonc.2016.08.002
|
[23]
|
Rudnicka, K., Backert, S. and Chmiela, M. (2019) Genetic Polymorphisms in Inflammatory and Other Regulators in Gastric Cancer: Risks and Clinical Consequences. In: Backert, S., Eds., Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter pylori, Vol. 421, Springer, Cham, 53-76.
https://doi.org/10.1007/978-3-030-15138-6_3
|
[24]
|
Loganathan, R., Nazeer, M., Goda, V., Devaraju, P., Ali, M., Karunakaran, P., et al. (2017) Genetic Variants of TLR4 and TLR9 Are Risk Factors for Chronic Helicobacter pylori Infection in South Indian Tamils. Human Immunology, 78, 216-220. https://doi.org/10.1016/j.humimm.2016.12.002
|
[25]
|
Tongtawee, T., Simawaranon, T., Wattanawongdon, W., Dechsukhum, C. and Leeanansaksiri, W. (2019) Toll-Like Receptor 2 and 4 Polymorphisms Associated with Helicobacter pylori Susceptibility and Gastric Cancer. The Turkish Journal of Gastroenterology, 30, 15-20.
|
[26]
|
Li, Z., Gao, H., Liu, Y., Wu, H., Li, W., Xing, Y., et al. (2021) Genetic Variants in the Regulation Region of TLR4 Reduce the Gastric Cancer Susceptibility. Gene, 767, Article ID: 145181. https://doi.org/10.1016/j.gene.2020.145181
|
[27]
|
Wang, Y., Zhang, C. and He, X. (2018) Minor Allele of rs1057317 Polymorphism in TLR4 Is Associated with Increased Risk of Helicobacter pylori-Induced Gastric Cancer. Journal of Cellular Biochemistry, 120, 1969-1978.
https://doi.org/10.1002/jcb.27493
|
[28]
|
De Re, V., Repetto, O., De Zorzi, M., Casarotto, M., Tedeschi, M., Giuffrida, P., et al. (2019) Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer. Cancers, 11, Article No. 648. https://doi.org/10.3390/cancers11050648
|
[29]
|
Xu, T., Fu, D., Ren, Y., Dai, Y., Lin, J., Tang, L., et al. (2017) Genetic Variations of TLR5 Gene Interacted with Helicobacter pylori Infection among Carcinogenesis of Gastric Cancer. Oncotarget, 8, 31016-31022.
https://doi.org/10.18632/oncotarget.16050
|
[30]
|
Flentie, K., Gonzalez, C., Kocher, B., Wang, Y., Zhu, H., Marasa, J., et al. (2018) Nucleoside Diphosphate Kinase-3 (NME3) Enhances TLR5-Induced NFB Activation. Molecular Cancer Research, 16, 986-999.
https://doi.org/10.1158/1541-7786.MCR-17-0603
|
[31]
|
Terawaki, K., Kashiwase, Y., Uzu, M., Nonaka, M., Sawada, Y., Miyano, K., et al. (2018) Leukemia Inhibitory Factor via the Toll-Like Receptor 5 Signaling Pathway Involves Aggravation of Cachexia Induced by Human Gastric Cancer-Derived 85As2 Cells in Rats. Oncotarget, 9, 34748-34764. https://doi.org/10.18632/oncotarget.26190
|
[32]
|
Jiang, J., Dong, L., Qin, B., Shi, H., Guo, X. and Wang, Y. (2016) Decreased Expression of TLR7 in Gastric Cancer Tissues and the Effects of TLR7 Activation on Gastric Cancer Cells. Oncology Letters, 12, 631-636.
https://doi.org/10.3892/ol.2016.4617
|
[33]
|
Wang, X., Liu, Y., Diao, Y., Gao, N., Wan, Y., Zhong, J., et al. (2018) Gastric Cancer Vaccines Synthesized Using a TLR7 agonist and Their Synergistic Antitumor Effects with 5-Fluorouracil. Journal of Translational Medicine, 16, Article No. 120. https://doi.org/10.1186/s12967-018-1501-z
|
[34]
|
Varga, M., Shaffer, C., Sierra, J., Suarez, G., Piazuelo, M.B., Whitaker, M.E., et al. (2016) Pathogenic Helicobacter pylori Strains Translocate DNA and Activate TLR9 via the Cancer-Associated Cag Type IV Secretion System. Oncogene, 35, 6262-6269. https://doi.org/10.1038/onc.2016.158
|
[35]
|
Dooyema, S., Krishna, U., Loh, J., Suarez, G., Cover, T.L. and Peek, RM. (2021) Helicobacter pylori-Induced TLR9 Activation and Injury Are Associated with the Virulence-Associated Adhesin HopQ. The Journal of Infectious Diseases, 224, 360-365. https://doi.org/10.1093/infdis/jiaa730
|
[36]
|
Nagase, H., Takeoka, T., Urakawa, S., Morimoto-Okazawa, A., Kawashima, A., Iwahori, K., et al. (2017) ICOS+ Foxp3+ TILs in Gastric Cancer Are Prognostic Markers and Effector Regulatory T Cells Associated with Helicobacter pylori. International Journal of Cancer, 140, 686-695. https://doi.org/10.1002/ijc.30475
|
[37]
|
Dargiene, G., Streleckiene, G., Skieceviciene, J., Leja, M., Link, A., Wex, T., et al. (2018) TLR1 and PRKAA1 Gene Polymorphisms in the Development of Atrophic Gastritis and Gastric Cancer. Journal of Gastrointestinal and Liver Diseases, 27, 363-369. https://doi.org/10.15403/jgld.2014.1121.274.tlr
|
[38]
|
Tongtawee, T., Bartpho, T., Kaewpitoon, S., Kaewpitoon, N., Dechsukhum, C., Leeanansaksiri, W., et al. (2016) TLR1 Polymorphism Associations with Gastric Mucosa Morphologic Patterns on Magnifying NBI Endoscopy: A Prospective CrossSectional Study. Asian Pacific Journal of Cancer Prevention, 17, 3391-3394.
https://doi.org/10.7314/APJCP.2016.17.3.1057
|
[39]
|
Pachathundikandi, S. and Backert, S. (2016) Differential Expression of Interleukin 1β During Helicobacter pylori Infection of Toll-Like Receptor 2 (TLR2)- and TLR10-Expressing HEK293 Cell Lines. The Journal of Infectious Diseases, 214, 166-167. https://doi.org/10.1093/infdis/jiw154
|